Full List Of Stories
Broker tips: Kaz Minerals, Micro Focus, Reach
RBC Capital Markets initiated coverage of copper miner Kaz Minerals at 'sector perform' with a 590p price target, as it said the stock looks fairly valued.
Barclays reiterates 'equal weight' on Reach following impressive end of year
Analysts at Barclays reiterated their 'equal weight' rating on British newspaper, magazine and digital publisher Reach on Monday, highlighting the firm's "impressive end to the year".
Director dealings: Outgoing GVC CFO ups stake
Outgoing GVC Holdings chief financial officer Paul Bowtell purchased 100,000 ordinary shares in the FTSE 100-listed gambling outfit.
US open: Dow Jones extends worst December opening in 38 years with early losses
US stocks turned south at the open on Monday as investors eyed the latest policy announcement from the Federal Reserve due later this week amid expectations of a 25 basis points rate hike.
Springfield Properties eyes interim dividend following strong start to trading year
AIM-listed house builder Springfield Properties has seen continued good progress in the first half of its trading year and now expects revenue and profit growth to be in line with management expectations.
Urals Energy oil subsidiary inexplicably buys unseaworthy passenger ship
Exploration and production outfit Urals Energy has been made aware of an irregular transaction made by one of its oil subsidiaries.
AppScatter snaps up digital security outfit Abilott
Mobile app management platform AppScatter has inked an agreement to acquire digital security outfit Abilott for as much as £2. 24m.
Safestyle losses widen following 'significant increase' in staffing
PVCu manufacturer Safestyle has seen a significant increase in its contracted workforce since inking a commercial agreement with an individual involved in its dispute with NIAMAC Developments back in October.
88 Energy secures all but one major permit at Alaskan asset
Exploration firm 88 Energy has been granted all but one major permit for its Winx-1 exploration drill on the North Slope of Alaska, with the group expecting to receive approval for its drilling permit in January 2019.
Summit Therapeutics proposes $25m fundraiser
Antibiotics developer Summit Therapeutics has entered into a securities purchase agreement for the sale of $25m worth of its US-listed shares in order to extend its cash runway through to January 2020.
RA International to fall short after project delays
Construction services outfit RA International has made some "good progress" on its strategic objectives since admission to trading on AIM earlier this year, but expects results to come in below expectations as a result of several project delays.